Quantcast
Channel: Orange Book Blog Feed
Browsing latest articles
Browse All 15 View Live

Federal Circuit Confirms That Isolated DNA May Be Patented

Assoc. for Molecular Pathology v. Myriad Genetics, No. 2010-1426 (Fed. Cir. 2011)[More...]

View Article


Federal Circuit Affirms Validity Of Argatroban Patent

Mitsubishi Chemical Corp. v. Barr Labs., No. 2010-1432 (Fed. Cir. 2011)[More...]

View Article


Federal Trade Commission Issues Final Report On Authorized Generic Drugs

The Federal Trade Commission announced earlier today that it has completed its study into the competitive effects of authorized generic drugs.  The FTC's final report, entitled "Authorized Generic...

View Article

Federal Circuit Confines 271(E)(1) Safe Harbor To Pre-Approval Activities

Classen Immunotherapies v. Biogen IDEC et al., Nos. 2006-1634, -1649 (Fed. Cir. 2011)[More...]

View Article

ACI "Advanced Forum On Biotech Patents" Conference, Boston, Nov. 30 - Dec. 1

American Conference Institute will be holding its 13th Advanced Forum on Biotech Patents conference at the Omni Parker House hotel in Boston, MA, November 30th to December 1st.  ACI subtitles this...

View Article


District Of Delaware Rules That API Manufacturer Cannot Be Sued Under Section...

by John L. Abramic[More...]

View Article

Federal Circuit Affirms Invalidity Of Teva's Patent On Rosuvastatin Formulation

Teva Pharm. Indus. Ltd. v. AstraZeneca Pharms. LP, No. 2011-1091 (Fed. Cir.)[More...]

View Article

Federal Circuit Vacates Preliminary Injunction Entered Against Mylan In...

Warner Chilcott Labs. v. Mylan Pharms. Inc., No. 2011-1611 (Fed. Cir.)[More...]

View Article


Cephalon Ordered To Pay Anchen's Attorney Fees For Maintaining Suit Despite...

In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, No. 09-MD-2118-SLR (D. Del.)[More...]

View Article


Federal Circuit: Section Viii Statement Avoids Infringement Under § 271(E)(2)

AstraZeneca Pharms. v. Apotex et al., No. 11-1182 (Fed. Cir.)[More...]

View Article

District Of Delaware: Paragraph IV Certification Not Required For...

Cephalon v. Sandoz, No. 11-821-SLR (D. Del.)[More...]

View Article

Third Circuit Issues Landmark Decision In Reverse Payment Case, Setting Up...

In Re: K-Dur Antitrust Litigation, No. 10-2077 (3d Cir.)[More...]

View Article

The America Invents Act: Basic Information for Patent Owners and Inventors

The United States passed a radically new patent statute, the Leahy-Smith America Invents Act ("AIA"), on September 16, 2011.  The AIA has some provisions already in effect and others that will become...

View Article


Novo Nordisk Requests FDA Advisory Opinion Concerning Orange Book Listing Of...

Novo Nordisk recently became the fourth company to ask FDA for guidance concerning whether patents on pre-filled drug delivery devices should be listed in the Orange Book.  Novo markets several drug...

View Article

"Defective" Complaint Triggers 30-Month Stay

In an opinion filed on Monday, the U.S. District Court for the District of Delaware granted leave to Endo Pharmaceuticals to file an amended complaint to correct a defective initial complaint.  In...

View Article

Browsing latest articles
Browse All 15 View Live